MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
568.89%
Quick Ratio
568.89%
Cash Ratio
478.70%
Debt to Asset Ratio
16.89%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid materials
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
26,094
31,718
41,299
51,845
Restricted cash
110
110
110
110
Prepaid materials
3,013
3,013
3,081
3,143
Prepaid expenses and other current assets
1,793
1,827
1,128
580
Total current assets
31,010
36,668
45,618
55,678
Other assets
1,271
1,275
1,990
2,334
Total assets
32,281
37,943
47,608
58,012
Accounts payable
1,976
2,569
4,293
3,536
Accrued expenses
1,380
2,807
1,307
1,989
Payroll liabilities
972
943
1,558
1,125
Other current liabilities
1,123
1,138
1,097
1,575
Total current liabilities
5,451
7,457
8,255
8,225
Total liabilities
5,451
7,457
8,255
8,225
Common stock - 0.18 par value 350,000,000 shares authorized 9,979,298 and 8,611,361 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
1,796
1,550
1,550
23,488
Additional paid-in capital
291,151
286,562
285,840
263,399
Treasury stock, at cost 88,003 shares of common stock at june 30, 2026 and december 31, 2025
1,475
1,475
1,475
1,475
Accumulated deficit
-264,642
-256,151
-246,562
-235,625
Total stockholders' equity
26,830
30,486
39,353
49,787
Total liabilities and stockholders' equity
32,281
37,943
47,608
58,012
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$26,094K (-54.90%↓ Y/Y)Prepaid materials$3,013K (-13.29%↓ Y/Y)Prepaid expenses andother current assets$1,793K (66.79%↑ Y/Y)Restricted cash$110K (0.00%↑ Y/Y)Total current assets$31,010K (-50.40%↓ Y/Y)Other assets$1,271K (-36.39%↓ Y/Y)Total assets$32,281K (-49.96%↓ Y/Y)Total liabilities andstockholders' equity$32,281K (-49.96%↓ Y/Y)Total stockholders'equity$26,830K (-53.50%↓ Y/Y)Total liabilities$5,451K (-20.07%↓ Y/Y)Accumulated deficit-$264,642K (-16.62%↓ Y/Y)Treasury stock, at cost88,003 shares of common...$1,475K (0.00%↑ Y/Y)Additional paid-in capital$291,151K (10.87%↑ Y/Y)Total currentliabilities$5,451K (-20.07%↓ Y/Y)Common stock - 0.18 parvalue 350,000,000...$1,796K (-92.35%↓ Y/Y)Accounts payable$1,976K (-1.69%↓ Y/Y)Accrued expenses$1,380K (-37.27%↓ Y/Y)Other currentliabilities$1,123K (-27.83%↓ Y/Y)Payroll liabilities$972K (-7.78%↓ Y/Y)

ATOSSA THERAPEUTICS, INC. (ATOS)

ATOSSA THERAPEUTICS, INC. (ATOS)